Industrial Policy & Trade Monitor· 2666 actions· ✨ 90 recent

On 19 May 2026, Treasurer Jim Chalmers announced a further overhaul of Australia's foreign investment framework under the Foreign Acquisitions and Takeovers Act 1975. The package introduces a performance target of processing all low-risk applications within 30 days from 1 January 2027, expands the exemption-certificate regime for repeat low-risk investors, and eliminates approval requirements for certain low-risk transaction types. Countervailing measures tighten the framework: enhanced compliance and enforcement powers are added for avoidance and non-compliance, and screening requirements are explicitly increased for sensitive sectors including critical minerals, critical infrastructure, critical technology, sensitive data, and defence-site-proximate assets.

The National Reconstruction Fund Corporation (NRFC), Australia's AUD 15 billion sovereign industrial-financing vehicle, took a AUD 20 million preferred-equity stake in Omniscient Neurotechnology, a Sydney-founded clinical connectomics company, announced 16 January 2026. The investment forms part of Omniscient's broader Series D raise (reported at up to AUD 36 million / USD 27.2 million) alongside Australian venture fund OIF Ventures, and is earmarked to commercialise Omniscient's Quicktome AI brain-mapping platform globally and expand its data-science team. NRFC frames the deal as building sovereign AI/medical-technology capability and creating over 40 new skilled jobs in Australia.

The National Reconstruction Fund Corporation (NRFC), Australia's AUD 15 billion sovereign industrial-financing vehicle, committed AUD 100 million (~USD 66 million) of senior secured debt to Intellihub, a Sydney-based smart-meter and grid-data operator managing over 3.3 million meters nationally, announced 2 December 2025. The debt tranche sits inside a broader AUD 3.1 billion debt funding package and is earmarked for continued smart-meter rollout and upgrades to Intellihub's Evergen energy-management software, which supports virtual power plant and demand-response operations. NRFC classifies the deal as its first deployment in the Renewables and Low Emissions Technology priority area, framing it as decarbonisation-enabling grid infrastructure rather than a greenfield manufacturing build.

The Australian Renewable Energy Agency (ARENA) awarded a AUD 25.3 million grant to Sydney-based startup SunDrive Solar to scale and commercialise its copper-metallisation solar cell technology at its Kurnell (New South Wales) facility, taking the process from R&D toward a 300 MW commercial-scale production line. The technology replaces silver — the metallisation material used in conventional solar cell manufacturing — with copper, a direct response to silver prices having nearly tripled over three years while the solar industry now consumes roughly a third of global industrial silver supply. The grant builds on an earlier AUD 14 million ARENA award and is delivered under the Advancing Renewables Program, with equipment partners Maxwell and Vistar supporting production-tool development, cost modelling and module testing.

The Australian Renewable Energy Agency (ARENA) announced up to AUD 45 million in funding for Fortescue's Solar Innovation Hub, a 500 MW test bed within Fortescue's 1.5 GW solar PV development pipeline at the Cloudbreak Solar Farm in the Pilbara region of Western Australia. The funding uses a portfolio structure covering up to 10 individual demonstration projects under one agreement, including Built Robotics' automated pile-driving technology and 5B's rapid-deployment Maverick solar system, aimed at cutting installed solar costs and supporting ARENA's Ultra Low-Cost Solar goal of 30% module efficiency at 30 cents/watt installed cost by 2030. Global Trade Alert logged the grant as a trade-distorting subsidy to Fortescue's solar manufacturing and deployment activity.

The National Reconstruction Fund Corporation (NRFC), Australia's AUD 15 billion sovereign industrial-financing vehicle, took a AUD 54 million (~USD 35 million) equity stake in Synchron, a Melbourne-founded (now US-headquartered) brain-computer interface company, announced 7 November 2025. The investment forms part of Synchron's broader ~AUD 305-308 million (~USD 200 million) Series D raise alongside investors including Qatar Investment Authority, In-Q-Tel and Double Point Ventures, and is earmarked to fund final clinical trials and US FDA regulatory approval of Synchron's Stentrode device — a minimally-invasive BCI implanted via blood vessel without open brain surgery. NRFC frames the deal as commercialising Australian-origin technology and building sovereign medical-device manufacturing and clinical-trial capability.

The Australian Renewable Energy Agency (ARENA) awarded a AUD 25 million grant to Melbourne battery-technology startup Relectrify to fast-track commercial deployment of its "AC1" battery energy storage system (BESS), a world-first design that eliminates the separate inverter by using a cell-level battery management system to produce AC power directly. The funding supports up to 100 MWh of AC1 deployments targeting commercial, industrial and small front-of-meter markets, generating operational performance data and reference installations, and builds on ARENA's earlier support for Relectrify's second-life EV-battery work.

The Australian Renewable Energy Agency (ARENA) committed AUD 44.9 million to Calix Limited to build a demonstration plant for its Zero Emissions Steel Technology (ZESTY), targeting up to 30,000 tonnes per year of low-carbon hydrogen direct reduced iron (HDRI) and hot briquetted iron (HBI) using renewable electricity and hydrogen instead of coking coal. The funding builds on prior ARENA-funded engineering studies and also supports early-stage engineering for a larger commercial-scale ZESTY plant, positioning low-emissions iron/steel as a strategic priority industry for Australia.

The National Reconstruction Fund Corporation (NRFC), Australia's AUD 15 billion sovereign industrial-financing vehicle, committed AUD 150 million to Brandon Capital's Brandon BioCatalyst 6 (BB6) fund, announced 24 July 2025. Brandon Capital — Australasia's largest life-sciences venture capital manager, with over AUD 1 billion under management — closed BB6 at AUD 439 million total, with the NRFC contribution the largest single commitment. The fund backs early- and late-stage Australian medical-science companies developing therapeutics, medical devices and vaccines, with roughly one-third earmarked for early-stage ventures and the remainder for late-stage clinical development and commercialisation. NRFC frames the deal as building sovereign medical-manufacturing and R&D capability and keeping Australian biotech IP and jobs onshore rather than migrating offshore for follow-on capital.

The National Reconstruction Fund Corporation (NRFC), Australia's AUD 15 billion sovereign industrial-financing vehicle, took a AUD 27 million equity stake in PolyActiva, a Melbourne biotech developing a biodegradable ocular implant (Prezia/PA5108) that delivers glaucoma medication over 6-12 months as an alternative to daily eye drops. The investment, announced 30 May 2025, forms the majority of PolyActiva's AUD 40 million Series C round, with the remaining AUD 13 million from existing investor Brandon Capital. Funds will consolidate the company's R&D, analytics and manufacturing into a single Melbourne facility, grow its ~25-person workforce, and fund completion of a Phase 2b clinical trial, with commercialisation targeted for 2029.

The Australian Renewable Energy Agency (ARENA) awarded up to AUD 46 million to Australian solar technology company 5B under Round 1A of the Solar Sunshot Program, the first funding decision under the AUD 1 billion program. The award comprises up to AUD 26 million in production credits tied to Australian-based manufacturing of 5B's "Maverick" prefabricated, prewired solar deployment system, plus a AUD 20 million capital grant for technology design improvements. The funding is intended to expand 5B's Adelaide manufacturing capacity to at least 200 MW of Maverick units per year over three years and is expected to cut the company's Australian production costs by 25%.

The Defence and Strategic Goods List (DSGL) 2024 was registered on the Federal Register of Legislation on 16 August 2024 under the Customs Act 1901 and Defence Trade Controls Act 2012, repealing and replacing the DSGL 2021. It comprises the Munitions List (Part 1) and the Dual-Use List (Part 2, nine technology categories including nuclear materials, chemicals, electronics, sensors and marine and aerospace equipment) that Australia controls for export, brokering and intangible transfer. The 2024 instrument periodically realigns the list with changes agreed in the multilateral non-proliferation and export-control regimes Australia belongs to (Wassenaar Arrangement, Missile Technology Control Regime, Nuclear Suppliers Group, Australia Group); most changes are clarifications to existing controls, with a smaller number of items entering or leaving control or having their approval requirements adjusted.

The Defence Trade Controls Amendment Act 2024 (C2024A00021) received Royal Assent on 8 April 2024 and created three new criminal offences in the Defence Trade Controls Act 2012: section 10A (supply of Defence and Strategic Goods List technology in Australia to a non-exempt foreign person); section 10B (secondary supply of DSGL Part 1 Munitions or Part 2 Dual-Use Sensitive/Very Sensitive goods or technology outside Australia when originally exported from Australia); and section 10C (provision of DSGL Part 1 services to foreign nationals outside Australia). All three offences carry maximum penalties of 10 years imprisonment or 2,500 penalty units (~A$782,500), or both. The offence framework commenced 1 September 2024 with a six-month compliance-transition period; criminal liability attached from 1 March 2025. The Act also codifies AUKUS-partnership exemptions, carving out supplies to and from citizens and permanent residents of the United Kingdom and United States, underpinning the licence-free trilateral technology-transfer environment sought under AUKUS Pillar 2.

On 22 July 2021, Australia's Minister for Industry, Science and Technology announced an AUD 14.8 million Modern Manufacturing Initiative grant to Lynas Rare Earths for a new Rare Earth Carbonate Refining Circuit at its planned Kalgoorlie, Western Australia processing facility. The published GrantConnect award record (GA200152, approved 16 June 2021) lists the contracted grant value to recipient Lynas Kalgoorlie Pty Ltd at AUD 15,618,958.30 (GST inclusive). The process reduces chemical consumption and processing cost for refining ore from Lynas's Mt Weld deposit onshore in Australia, reducing reliance on Chinese midstream rare earth refining capacity.